- Home
- SKY vs AKRO Comparison
SKY vs AKRO Comparison
Compare SKY & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKY | AKRO |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.5B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SKY | AKRO |
|---|---|---|
| Price | $85.24 | $54.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $85.00 | $73.56 |
| AVG Volume (30 Days) | 640.4K | ★ 1.7M |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.48 | N/A |
| EPS | ★ 3.84 | N/A |
| Revenue | ★ $2,624,539,000.00 | N/A |
| Revenue This Year | $7.67 | N/A |
| Revenue Next Year | $4.67 | N/A |
| P/E Ratio | $22.25 | ★ N/A |
| Revenue Growth | ★ 12.14 | N/A |
| 52 Week Low | $59.44 | $21.34 |
| 52 Week High | $116.49 | $58.40 |
Technical Indicators
Market Signals| Indicator | SKY | AKRO |
|---|---|---|
| Relative Strength Index (RSI) | 61.66 | 66.54 |
| Support Level | $83.25 | $54.22 |
| Resistance Level | $87.17 | $54.70 |
| Average True Range (ATR) | 2.76 | 0.14 |
| MACD | 0.08 | -0.11 |
| Stochastic Oscillator | 81.63 | 64.18 |
Price Performance
Historical ComparisonAbout SKY Skyline Champion Corporation
Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.